Cenderitide

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Cenderitide
Accession Number
DB11777
Type
Biotech
Groups
Investigational
Biologic Classification
Protein Based Therapies
Other protein based therapies
Description

Cenderitide is under investigation for the treatment of ST Elevation (STEMI) Myocardial Infarction of Anterior Wall.

Protein chemical formula
Not Available
Protein average weight
Not Available
Sequences
Not Available
Synonyms
  • CD-NP
Categories
UNII
9NKZ9LYZ06
CAS number
507289-11-4

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347911241
Wikipedia
Cenderitide

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedNot AvailableAcute Decompensated Heart Failure (ADHF) / Chronic Heart Failure (CHF) / Congestive Heart Failure / Heart Failure1
1CompletedNot AvailableLeft Ventricular Assist Device's in Patients / Left Ventricular Insufficiency1
1CompletedBasic ScienceStable Chronic Heart Failure1
1CompletedTreatmentCongestive Heart Failure2
1CompletedTreatmentST Elevation (STEMI) Myocardial Infarction of Anterior Wall1
1WithdrawnTreatmentHeart Failure / Left Ventricular Assist Device / Natriuretic Peptide1
1WithdrawnTreatmentHeart Failure / Impaired kidney function1
1, 2CompletedTreatmentHeart Failure / Impaired kidney function1
2CompletedTreatmentAcute Decompensated Heart Failure (ADHF)2
2CompletedTreatmentHeart Failure1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available

Drug created on October 20, 2016 14:47 / Updated on March 01, 2020 20:59

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates